Susceptibility to cefoperazone/sulbactam of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Yishan Huang, Fang Li, SU Zhong-long, Zhu Xing-chun, Lin Fang, He Ying, Huo Ya-ping
Abstract
Yishan Huang, Fang Li, SU Zhong-long, Zhu Xing-chun, Lin Fang, He Ying, Huo Ya-ping
Abstract
OBJECTIVE To detect metallo-β-lactamases(MBLs) produced by multidrug-resistant Acinetobacter baumannii(MDR-AB) and multidrug resistant Pseudomonas aeruginosa(MDR-PA) in our hospital and their resistance to cefoperazone/sulbactam.METHODS VITEK-32,GNS-132 system,routine test were used to detect non-duplicating A.baumannii(42 strains) and P.aeruginosa(95 strains),while Etest used to detect MBLs and K-B method to detect drug sensitivity to cefoperazone/sulbactam and polymyxin E.The sensitivity of two different drug-resistant phenotypes to cefoperazone/sulbactam was and analyzed.RESULTS The imipenem resistance rate of A.baumannii and P.aeruginosa was 66.7% and 31.6%,respectively.MRD-AB and MRD-PA had more MBLs strains.The sensitivity of imipenem-resistant van-producing MBLs strains to cefoperazone/sulbactam statistically was without significant difference,while that with MBLs was with significant difference(P0.05).CONCLUSIONS The sensitivity to cefoperazone/sulbactam of MDR-AB is higher than that of MDR-PA.Cefoperazone/sulbactam can be choose to treat MDR-AB with imipenem resistance MDR-PA with imipenem resistance especially producing metallo β-lactamases,can be treated with polymyxin E or its combination.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To detect metallo-β-lactamases(MBLs) produced by multidrug-resistant Acinetobacter baumannii(MDR-AB) and multidrug resistant Pseudomonas aeruginosa(MDR-PA) in our hospital and their resistance to cefoperazone/sulbactam.METHODS VITEK-32,GNS-132 system,routine test were used to detect non-duplicating A.baumannii(42 strains) and P.aeruginosa(95 strains),while Etest used to detect MBLs and K-B method to detect drug sensitivity to cefoperazone/sulbactam and polymyxin E.The sensitivity of two different drug-resistant phenotypes to cefoperazone/sulbactam was and analyzed.RESULTS The imipenem resistance rate of A.baumannii and P.aeruginosa was 66.7% and 31.6%,respectively.MRD-AB and MRD-PA had more MBLs strains.The sensitivity of imipenem-resistant van-producing MBLs strains to cefoperazone/sulbactam statistically was without significant difference,while that with MBLs was with significant difference(P0.05).CONCLUSIONS The sensitivity to cefoperazone/sulbactam of MDR-AB is higher than that of MDR-PA.Cefoperazone/sulbactam can be choose to treat MDR-AB with imipenem resistance MDR-PA with imipenem resistance especially producing metallo β-lactamases,can be treated with polymyxin E or its combination.
Key concepts: Cefoperazone, Acinetobacter baumannii, Sulbactam, Microbiology, Imipenem, Etest, Pseudomonas aeruginosa, Multiple drug resistance